
Read More
In conversation with Pranav Amin, Managing Director, Alembic Pharmaceutical...
Driving Sustainable Growth Through Complex Generics, Specialty Products and Global Expansion...

Driving Sustainable Growth Through Complex Generics, Specialty Products and Global Expansion...

In the last 12 months, the stock is down by 8.99 per cent while from its 52-week low it is up by 20....

Shares of the company zoomed 8 per cent on getting the final nod for Ketorolac Tromethamine Injectio...